Tech Company Financing Transactions

Mirum Pharmaceuticals Funding Round

Mirum Pharmaceuticals secured a $120 million Series A funding round on 11/8/2018. Backers included New Enterprise Associates, Deerfield Capital and Frazier Healthcare Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

950 Tower Ln. 1050
Foster City, CA 94404
USA

Phone

650-667-4085

Website

www.mirumpharma.com

Email Address

[email protected]

Overview

Mirum Pharmaceuticals Inc. (Nasdaq: MIRM) is a therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Michael Grey

        

Chief Executive Officer

Chris Peetz

        

Chief Financial Officer

Ian Clements

        

Chief Medical Officer

Ed Tucker

        

Chief Operating Officer

Peter Radovich

        

VP - Bus. Development

Lara Longpre

        

Browse more venture capital transactions:

Prev: 11/8/2018: YotaScale venture capital transaction
Next: 11/9/2018: Opternative venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary